In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, GlaxosmithKline Pharmaceuticals has informed that it has enclosed a copy of the Certificate received from Kfintech, the Registrar and share Transfer Agent of the Company, for the quarter ended 31st March 2021.
The above information is a part of company’s filings submitted to BSE.